InvestorX
SEDAR® Issuer number:
00045594
Company name:
NAVCO Pharmaceuticals Inc. (formerly, BMGB Capital Corp.)
Document type:
Statement of executive compensation (form 51-102F6V) - English
Project number:
06107125
Filing date:
03-28-2024